Literature DB >> 20177411

A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.

David Pejoski1, Weiguang Zeng, Steven Rockman, Lorena E Brown, David C Jackson.   

Abstract

A conserved 15 amino-acid residue sequence of the ectodomain of the M2 protein of influenza A virus (M2e) induces a strong antibody (Ab) response when incorporated into a synthetic lipopeptide vaccine candidate containing a T-helper epitope from influenza A hemagglutinin and the dendritic cell-targeting lipid moiety S-[2,3-bis(palmitoyloxy)propyl]cysteine (Pam2Cys). Abs elicited by the truncated M2e sequence were specific for the M2 protein of influenza A virus and were also capable of binding to cells that were infected with influenza A viruses of different subtypes. The Ab titres against the lipopeptide were similar in magnitude to those elicited by the full-length (23 residue) M2e peptide when administered in Freund's adjuvant. Abs to the truncated M2e sequence were also able to significantly reduce the viral load in airways of BALB/c mice after challenge with live influenza virus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20177411     DOI: 10.1038/icb.2010.15

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  16 in total

1.  A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope building.

Authors:  Weiguang Zeng; Kylie J Horrocks; Gorjana Robevska; Chinn Yi Wong; Kristy Azzopardi; Marija Tauschek; Roy M Robins-Browne; David C Jackson
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

2.  Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.

Authors:  Hamidreza Hashemi; Somayeh Pouyanfard; Mojgan Bandehpour; Zahra Noroozbabaei; Bahram Kazemi; Xavier Saelens; Talat Mokhtari-Azad
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

3.  Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling.

Authors:  Amit A Lugade; Anna Bianchi-Smiraglia; Vandana Pradhan; Galina Elkin; Timothy F Murphy; Yasmin Thanavala
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

4.  Prevention and treatment of influenza with hyperimmune bovine colostrum antibody.

Authors:  Wy Ching Ng; Victor Wong; Brian Muller; Grant Rawlin; Lorena E Brown
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

5.  Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.

Authors:  Amaya I Wolf; Krystyna Mozdzanowska; Katie L Williams; David Singer; Monique Richter; Ralf Hoffmann; Andrew J Caton; Laszlo Otvos; Jan Erikson
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

6.  Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.

Authors:  Lei Deng; Lorena Itatí Ibañez; Veronique Van den Bossche; Kenny Roose; Sameh A Youssef; Alain de Bruin; Walter Fiers; Xavier Saelens
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

Review 7.  Universal influenza vaccines, a dream to be realized soon.

Authors:  Han Zhang; Li Wang; Richard W Compans; Bao-Zhong Wang
Journal:  Viruses       Date:  2014-04-29       Impact factor: 5.048

8.  Different arms of the adaptive immune system induced by a combination vaccine work in concert to provide enhanced clearance of influenza.

Authors:  Joanna C A Cobbin; Weiguang Zeng; David C Jackson; Lorena E Brown
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

Review 9.  M2e-Based Universal Influenza A Vaccines.

Authors:  Lei Deng; Ki Joon Cho; Walter Fiers; Xavier Saelens
Journal:  Vaccines (Basel)       Date:  2015-02-13

10.  Epitope Mapping of Avian Influenza M2e Protein: Different Species Recognise Various Epitopes.

Authors:  Noor Haliza Hasan; Esmaeil Ebrahimie; Jagoda Ignjatovic; Simson Tarigan; Anne Peaston; Farhid Hemmatzadeh
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.